Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (avilamycin and evernimicin)

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 12, 2000, Pages 3425-3427

  Aarestrup, F M ^a   Jensen, L B ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; AVILAMYCIN; BACTERIAL PROTEIN; EVERNIMICIN; HISTIDINE; ISOLEUCINE; OLIGOSACCHARIDE; PROTEIN L16; RIBOSOME PROTEIN; SERINE; THREONINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENE SEQUENCE; GENETIC ANALYSIS; NONHUMAN; PRIORITY JOURNAL;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; DNA, BACTERIAL; ENTEROCOCCUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; RIBOSOMAL PROTEINS; VARIATION (GENETICS);

EID: 0034426125     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.12.3425-3427.2000     Document Type: Article

References (16)

1. Association between decreased susceptibility to a new antibiotic for treatment of human diseases, evernimicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin
2. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark
3. The association between the use of avilamycin for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers and pigs. Epidemiological study and changes over time
4. Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans
5. Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: The role of streptogramins and other newer compounds
6. Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: Disk diffusion/etest method evaluations and quality control guidelines
7. Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria
8. Everninomicin, a new oligosaccharide antibiotic: Its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity
9. Major trends in the microbial etiology of nosocomial infection
10. Antimicrobial susceptibility patterns of enterococci causing infections in Europe
11. Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen
12. Hospital-acquired infections: Diseases with increasingly limited therapies
13. Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin
14. Purification and biological studies of everninomicin B
15. Avilamycin, an inhibitor of the 30 S ribosomal subunits function